Product NDC: | 0019-1323 |
Proprietary Name: | Optiray |
Non Proprietary Name: | Ioversol |
Active Ingredient(s): | 678 mg/mL & nbsp; Ioversol |
Administration Route(s): | INTRA-ARTERIAL; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0019-1323 |
Labeler Name: | Mallinckrodt Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019710 |
Marketing Category: | NDA |
Start Marketing Date: | 20120304 |
Package NDC: | 0019-1323-73 |
Package Description: | 20 SYRINGE, PLASTIC in 1 CARTON (0019-1323-73) > 30 mL in 1 SYRINGE, PLASTIC |
NDC Code | 0019-1323-73 |
Proprietary Name | Optiray |
Package Description | 20 SYRINGE, PLASTIC in 1 CARTON (0019-1323-73) > 30 mL in 1 SYRINGE, PLASTIC |
Product NDC | 0019-1323 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ioversol |
Dosage Form Name | INJECTION |
Route Name | INTRA-ARTERIAL; INTRAVENOUS |
Start Marketing Date | 20120304 |
Marketing Category Name | NDA |
Labeler Name | Mallinckrodt Inc. |
Substance Name | IOVERSOL |
Strength Number | 678 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |